Single IRB Mandate
The move toward single IRB (sIRB) review is more than just a regulatory imperative. It represents a fundamental shift toward greater consistency and efficiency in the oversight of multisite clinical research. WCG brings deep IRB expertise and practical insights to help research organizations understand the FDA single IRB mandate, sIRB implementation, and strategies for navigating this evolving regulatory landscape.
WCG Clinical | Insights
Streamlining IRB Review in Clinical Research
Infographic
WCG Clinical | Insights
6 Ethical Considerations for Clinical Research Involving AI: What Sponsors and CROs Need to Know
Blog Posts
WCG Clinical | Insights
Framework for Review of Clinical Research Involving AI: Advancing Ethical Oversight in Clinical Research
Blog Posts
WCG Clinical | Insights
IRB Review for Federal Grants
Articles
WCG Clinical | Insights
What Is a Central IRB? Your FAQ Guide
Resource Hub
WCG Clinical | Insights
Pioneering Ethical Oversight in AI-Enabled Clinical Research: Insights on the New Framework
Blog Posts
WCG Clinical | Insights
FDA’s Proposed Rule for Single IRB Review in Cooperative Research
Blog Posts
WCG Clinical | Insights
FDA’s Single IRB Requirement, Expected but Not Guaranteed in 2025
Blog Posts
WCG Clinical | Insights
The Upcoming Single IRB Mandate and the Critical Role of Site Selection: Your Questions Answered
Blog Posts
WCG Clinical | Insights